Amanote Research
Register
Sign In
Genetic Alterations Associated With Acquired Temozolomide Resistance in SNB-19, a Human Glioma Cell Line
Molecular Cancer Therapeutics
- United States
doi 10.1158/1535-7163.mct-05-0428
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
September 1, 2006
Authors
N. Auger
Publisher
American Association for Cancer Research (AACR)
Related search
Genetic Alterations in Glioma
Cancers
Cancer Research
Oncology
Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
YKL-40 Downregulation Is a Key Factor to Overcome Temozolomide Resistance in a Glioblastoma Cell Line
Oncology Reports
Medicine
Cancer Research
Oncology
The Biological Characteristics of Glioma Stem Cells in Human Glioma Cell Line SHG44
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Genetic Alterations Associated With Cryptorchidism
JAMA - Journal of the American Medical Association
Medicine
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide
Molecular Cancer Therapeutics
Cancer Research
Oncology
Glycogenolysis in Acquired Glioma Resistance to Temozolomide: A Role for the [Ca2+]i-Dependent Activation of Na,K-ATPase/Erk1/2 Signaling
Frontiers in Pharmacology
Pharmacology
H19 Induced by Oxidative Stress Confers Temozolomide Resistance in Human Glioma Cells via Activating NF-κB Signaling
OncoTargets and Therapy
Oncology
Pharmacology
A Novel Cucumber Gene Associated With Systemic Acquired Resistance
Plant Science
Medicine
Genetics
Agronomy
Plant Science
Crop Science